IL17A and autoimmune disease: To demonstrate the role of SMADs in this pro-inflammatory cytokines-mediated EMT-dependent fibrosis program activated in pSS, the investigations have currently focused on IL-17 because accumulated data support a pivotal role of IL-17 as an attractive target for the individuation of new treatment for autoimmune diseases [102,103].